Elanco Animal Health (ELAN) Retained Earnings (2017 - 2026)

Elanco Animal Health has disclosed Retained Earnings across 10 years of filings, most recently posting -$2.1 billion for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$2.1 billion, down 264.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 billion (down 264.49% YoY), and the FY2025 annual result was -$141.0 million, up 81.71% from the prior year.
• Retained Earnings came in at -$2.1 billion for Q1 2026 at Elanco Animal Health, down from -$141.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$141.0 million in Q4 2025 to a low of -$2.1 billion in Q3 2023.
• The 5-year median for Retained Earnings is -$771.0 million (2024), against an average of -$856.8 million.
• Across the five-year window, Retained Earnings tumbled 1520.0% in 2022 and surged 89.75% in 2025, its largest moves.
• Elanco Animal Health's Retained Earnings stood at -$392.0 million in 2022, then surged by 32.14% to -$266.0 million in 2023, then slumped by 189.85% to -$771.0 million in 2024, then surged by 81.71% to -$141.0 million in 2025, then sank by 1407.09% to -$2.1 billion in 2026.
• The last three Retained Earnings figures came in at -$2.1 billion (Q1 2026), -$141.0 million (Q4 2025), and -$199.0 million (Q3 2025), per Business Quant data.